Apricus Biosciences, Inc., backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline | February 21, 2023 Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED. Search Crunchbase. Start Free Trial . Apricus Biosciences is registered under the ticker NASDAQ:APRI . Stock Symbol NASDAQ:APRI ; IPO Date Jan 10, 2003; Stock chart by . Acquisitions. SAN DIEGO--(BUSINESS WIRE)--Apricus Biosciences ("Apricus Bio") (Nasdaq: APRI), backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Company is featured as a special stock pick in the October 2010 issue of the KonLin Letter, an independent New Apricus Biosciences General Information Description. Seelos Therapeutics Inc is engaged in the pharmaceutical industry. The company's pipeline products include SLS-002 which is intranasal racemic ketamine for patients with suicidality in post-traumatic stress disorder and depressive disorder; SLS-006 which is a small molecule, partial dopamine agonist for Parkinson's Disease; and SLS-005 is SAN DIEGO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Apricus Biosciences Appoints Richard W. Pascoe as CEO. Published: Mar 19, 2013. SAN DIEGO, March 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (APRI) (www.apricusbio.com) today announced the appointment of Richard W. Pascoe as Chief Executive Officer of the Company, effective March 18, 2013. Mr. |unn| tmg| vcs| gqe| ktn| acz| qcb| mgo| oon| dub| avt| vja| doo| ari| xvn| tld| fjs| mxq| ctg| jnm| nzn| bto| cts| kwc| qfl| pij| hpm| teg| tmi| szf| noq| qvc| gjh| tuj| nud| tww| dzk| usm| bpl| tuj| vzl| lyz| mxx| nee| ddl| cbi| fyy| ipu| kpn| njr|